• Author: Sridharan Raghavan
Clear all

First-line β-blocker use for hypertension in the Veterans Health Administration

Abstract: Importance: Starting in 2014, US guidelines have not recommended β-blockers for first-line treatment of hypertension in the absence of compelling indications due to …

A qualitative study to investigate the nutrition perspectives and experiences of Veterans with CKD

Background: CKD affects susceptible populations at higher rates than the general public. Dietary adherence, quality, and behaviors play a crucial role in CKD and chronic disease …

Evidence-based SGLT2 inhibitor and GLP-1 receptor agonist use by race in the VA healthcare system

Abstract: Importance: Adoption of novel therapeutics often lags for Black versus non-Hispanic White patients. Seminal clinical trials established the cardiovascular efficacy of …

Cardiovascular health score and atherosclerotic cardiovascular disease in the Million Veteran Program

Abstract: Importance: The American Heart Association proposed Life's Essential 8 (LE8) as an enhanced measurement tool for cardiovascular health. Objective: To examine the …

Type 1 Diabetes Genetic Risk in 109,954 Veterans With Adult-Onset Diabetes: The Million Veteran Program (MVP)

Abstract: Objective: To characterize high type 1 diabetes (T1D) genetic risk in a population where type 2 diabetes (T2D) predominates. Research design and methods: Characteristics …